Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ACCELEVIR DIAGNOSTICS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-06-01 to 2025-05-31
Current total value of award: $2000000
Description: PROVIRAL SEQUENCING DRIVEN DEVELOPMENT OF ENHANCED IPDAV2 WITH GLOBAL HIV-1 GROUP M COVERAGE TO SUPPORT WORLDWIDE CURE AND CLINICAL TRIALS